RBI
TEVA icon

Raiffeisen Bank International’s Teva Pharmaceuticals TEVA Stock Holding History

Raiffeisen Bank International’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
48,176
+16,332
+51% +$544K 0.02% 344
2026
Q1 		$903K Buy
+31,844
New +$1.02M 0.01% 395
2025
Q3 		– Sell
-8,168
Closed -$143K – 903
2025
Q2 		$136K Hold
8,168
– – ﹤0.01% 454
2025
Q1 		$125K Hold
8,168
– – ﹤0.01% 471
2024
Q4 		$183K Buy
+8,168
New +$149K ﹤0.01% 448

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Raiffeisen Bank International's TEVA Position: Q2 2026 in Review

Raiffeisen Bank International increased its Teva Pharmaceuticals (TEVA) stake by 51% in Q2 2026, buying an estimated $544K and bringing the position to 48,176 shares worth $1.6M. The position accounts for 0.02% of the portfolio, ranked #344.

Raiffeisen Bank International first reported a position in TEVA in Q4 2024 and has held it in 5 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Raiffeisen Bank International held 48,176 shares of Teva Pharmaceuticals worth $1.6M as of Q2 2026.
  • Raiffeisen Bank International bought 16,332 Teva Pharmaceuticals shares in Q2 2026, an estimated $544K.
  • Teva Pharmaceuticals made up 0.02% of Raiffeisen Bank International's portfolio in Q2 2026, its #344 holding.
  • Raiffeisen Bank International first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.